|
|
|
|
|
|
|
|
|
|
Previous: FLEMINGTON PHARMACEUTICAL CORP, 10QSB, 2000-12-14 |
Next: FLEMINGTON PHARMACEUTICAL CORP, 10QSB, EX-27, 2000-12-14 |
EXHIBIT 11
FLEMINGTON PHARMACEUTICAL CORPORATION
EARNINGS PER SHARE COMPUTATION
(DOLLARS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)
THREE MONTHS ENDED
OCTOBER 31, 2000
------------------
BASIC
------------------
WEIGHTED AVERAGE SHARES OUTSTANDING 5,879,000
DILUTIVE EFFECT OF STOCK PERFORMANCE PLANS (1) --
------------------
TOTAL 5,879,000
NET INCOME (LOSS) (352)
------------------
EARNINGS PER SHARE (.06)
------------------
THREE MONTHS ENDED
OCTOBER 31, 1999
------------------
BASIC
------------------
WEIGHTED AVERAGE SHARES OUTSTANDING 3,877,000
DILUTIVE EFFECT OF STOCK PERFORMANCE PLANS (1) --
------------------
TOTAL 3,877,000
NET INCOME (LOSS) (217)
------------------
EARNINGS PER SHARE (.06)
------------------
(1) NO POTENTIAL SHARES FROM STOCK PERFORMANCE PLANS HAVE BEEN PRESENTED, AS
THEIR EFFECT WOULD BE ANTI-DILUTIVE
11
|
|